Jaime Sanchez shared her story of avoiding high-risk surgery for her fibroids by undergoing the Sonata Treatment at UConn Health. She was able to return to normal activities quickly, stating, “The next day I was able to go to work and I walked around fine and I had no pain.” Dr. Amanda Ulrich, who
HealthiHer Podcast – Treating Uterine Fibroids with Sonata: High Precision, No Incision with Dr. David Toub
Dr. David Toub, Senior Vice President of Medical Affairs at Gynesonics was featured on an episode of the HealthiHer podcast with host Dr. Amy Brenner. Tune in to this enlightening discussion as Dr. Brenner and Dr. Toub navigate the landscape of fibroid treatment, offering valuable insights into the
UConn Health Is the First and Only in Connecticut to Offer Innovative New Procedure to Treat Uterine Fibroids
UConn Health is the first in Connecticut to offer Sonata® treatment for uterine fibroids, providing a non-surgical, incisionless option using radiofrequency ablation. This procedure significantly reduces fibroid symptoms such as heavy and painful menstruation. Patient Jaime Sanchez, who underwent
Bon Secours Educates Women on Fibroid Awareness Month
In recognition of Fibroid Awareness Month, Dr. Edward Heidtman from Bon Secours recently shared insights on WSPA 7NEWS regarding advanced treatment options for fibroids and the importance of empowering women to take control of their health. His interview provides great information on managing
New, Incision-free Treatment Option for Uterine Fibroids Now Available at UP Health System – Portage
UP Health System – Portage is the first facility in Michigan's Upper Peninsula to offer Sonata Treatment for women with fibroids! This minimally invasive treatment offers relief from fibroids while preserving the uterus. Dr. Evon Schexnaydre, a recent addition to UPHS's OB/GYN team, calls Sonata "a
Gynesonics Announces Key Executive Appointments to Further Accelerate and Expand Adoption of the Sonata Treatment
REDWOOD CITY, CA, March 19, 2024 – Gynesonics®, Inc., a privately-held women’s healthcare medical device company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, is pleased to announce several executive appointments for the positions of Chief Marketing and